Amphastar Pharmaceuticals (AMPH) Market Capitalization (2014 - 2026)

Amphastar Pharmaceuticals has reported Market Capitalization for 13 years, with the latest figure at $858.3 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 19.59% year-over-year to $858.3 million in Q2 2026; TTM through Jun 2026 was $858.3 million, a 19.59% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 30.86% from the prior year.
• Market Capitalization was $858.3 million for Q2 2026 at Amphastar Pharmaceuticals, down from $874.4 million in the prior quarter.
• The five-year high for Market Capitalization was $3.0 billion in Q4 2023, with the low at $858.3 million in Q2 2026.
• Average Market Capitalization over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization jumped 120.54% in 2023, then tumbled 47.38% in 2025.
• Over 5 years, Market Capitalization stood at $1.3 billion in 2022, then surged by 120.54% to $3.0 billion in 2023, then sank by 40.53% to $1.8 billion in 2024, then tumbled by 30.86% to $1.2 billion in 2025, then retreated by 29.78% to $858.3 million in 2026.
• The last three Market Capitalization figures came in at $858.3 million (Q2 2026), $874.4 million (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.